Employees Retirement System Of Texas Exelixis, Inc. Transaction History

Employees Retirement System Of Texas

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$20.17 - $23.93 $1.07 Million - $1.27 Million	-52,950 Reduced 39.73%	80,310 $1.91 Million
Q2 2023 Aug 10, 2023	BUY	$18.17 - $20.48 $531,654 - $599,244	29,260 Added 28.13%	133,260 $2.55 Million
Q1 2023 Apr 26, 2023	BUY	$16.3 - $19.41 $1.7 Million - $2.02 Million	104,000 New	104,000 $2.02 Million
Q4 2021 Feb 15, 2022	SELL	$15.84 - $21.88 $587,664 - $811,748	-37,100 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$17.68 - $22.65 $917,592 - $1.18 Million	-51,900 Reduced 58.31%	37,100 $656,000
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $227,160 - $297,000	-12,000 Reduced 11.88%	89,000 $1.9 Million
Q3 2018 Nov 13, 2018	BUY	$15.87 - $22.4 $809,370 - $1.14 Million	51,000 Added 102.0%	101,000 $1.79 Million
Q2 2018 Aug 10, 2018	BUY	$18.56 - $22.45 $315,520 - $381,650	17,000 Added 51.52%	50,000 $1.08 Million
Q2 2017 Aug 14, 2017	BUY	N/A	33,000	33,000 $813,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.